Mon - Fri: 08:00 - 18.00 Sat - Sun: Closed
+44 (0)1625 238630 Call today

Related Posts

December 2020

Matrix Healthcare Solutions (MHS) has further complimented its expansive licensed capabilities with the addition of a Manufacturers Import Authorisation (MIA) for Investigational Medicinal Products (IMP). The stringent controls and high standards required for IMP management in clinical trials have a direct impact on product registration with regulatory and competent authorities around the world. The MIA (IMP) allows Matrix Healthcare Solutions to better serve its increasing global base of customers.